Speaker :

Dr. Chakor Vora, Medical Oncologist, Pune

Evaluation of 1-Year vs Shorter Durations of Adjuvant Trastuzumab Among Patients  With Early Breast Cancer An Individual Participant Data and Trial-Level Meta-analysis

Author: Seema Gulia  

Citation: JAMA Netw Open. 2020;3(8):e2011777

Author: Masataka Sawaki  

Citation: Journal of Clinical Oncology 38, no. 32 (November 10, 2020) 3743-3752 

Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus  standard-of-care chemotherapy in women with hormone receptor-positive,  HER2-positive advanced breast cancer (monarcHER): a randomised, open-label,   phase 2 trial 

Author: Sara M. Tolaney      

Citation: The Lancet VOLUME 21, ISSUE 6, P763-775, JUNE 01, 2020